Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Medpace First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Medpace Holdings Inc. (MEDP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 119,961 | $48,482,237 | -1% | 0.02% |
| 2. | McKinley Capital Management Robert B. Gillam | 13,970 | $5,645,976 | 0.67% | |
| 3. | Bailard Inc Thomas Bailard | 750 | $303,113 | 0% | |
| 4. | RiverPark Advisors Mitch Rubin | 554 | $223,899 | +545% | 0.18% |
| 5. | Solstein Capital Nadine Terman And Jc Torres | 67 | $27,078 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $154.59 | 57,426 | Large Shareholder | 6,483,019 | 2022-09-22 | Filing | |
| $154.59 | 57,426 | Large Shareholder, Officer, Director | 6,483,019 | 2022-09-22 | Filing | |
| $161.63 | 94,119 | Large Shareholder, Officer, Director | 6,425,593 | 2022-09-21 | Filing | |
| $155.14 | 94,119 | Large Shareholder, Officer, Director | 6,331,474 | 2022-09-20 | Filing | |
| $161.63 | 94,119 | Large Shareholder | 6,425,593 | 2022-09-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $404.48 | 28,032 | Large Shareholder, Officer, Director | 720,979 | 2024-05-07 | Filing | |
| $401.73 | 24,372 | Large Shareholder, Officer, Director | 749,011 | 2024-05-06 | Filing | |
| $400.44 | 3,396 | Large Shareholder, Officer, Director | 773,383 | 2024-05-02 | Filing | |
| $401.56 | 12,934 | Large Shareholder, Officer, Director | 776,779 | 2024-05-01 | Filing | |
| $400.31 | 1,828 | Large Shareholder, Officer, Director | 789,713 | 2024-04-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,556,443 | $783,626,472 | 0.01% | |
| 2. | 2,418,056 | $741,206,775 | 0.01% | |
| 3. | 1,186,181 | $363,600,062 | 2% | |
| 4. | 723,238 | $221,694,146 | 0.05% | |
| 5. | 671,145 | $205,726,077 | 0.01% |
News See All
Should You Invest in Medpace (MEDP)?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Medpace Holdings (MEDP) is Maintaining a Healthy Margin Profile
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds released “The RiverPark/Next Century Growth Fund” Q4 2023 investor letter in partnership with Next...
Should You Invest in Medpace (MEDP)?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Does Medpace Holdings (MEDP) Have The Potential to Maintain Strong Growth?
Next Century Growth Investors, LLC, an investment Management Company, released its “SMID Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
Insiders Are Selling These 5 Stocks in 2024
Ohio-based clinical research company Medpace Holdings Inc (NASDAQ:MEDP) ranks fifth in our list of the stocks insiders are selling in 2024. Medpace Holdings Inc's (NASDAQ:MEDP) CEO August J.
Does Medpace Holdings (MEDP) Have a Track Record of Robust Financial Performance?
Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts
In this article, we will take a look at the 10 stocks receiving a massive vote of approval from Wall Street analysts.
Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Medpace Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Do You Believe in the Growth Prospects of Medpace Holdings (MEDP)?
Investment management company Vulcan Value Partners recently released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
